Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Panbela Therapeutics Inc (NQ: PBLA )

0.5100 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,419
Open 0.5100
Bid (Size) 0.5000 (4)
Ask (Size) 0.5108 (28)
Prev. Close 0.5100
Today's Range 0.5100 - 0.5100
52wk Range 0.4100 - 87.60
Shares Outstanding 14,595,873
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Panbela Announces Issuance of New Patent in Japan; Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. 
From Panbela Therapeutics, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023
 
Via Benzinga

Performance

YTD
-84.45%
-84.45%
1 Month
-58.87%
-58.87%
3 Month
-84.02%
-84.02%
6 Month
-96.25%
-96.25%
1 Year
-99.41%
-99.41%

More News

Read More
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Preview For Panbela Therapeutics
Via Benzinga
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Panbela to Host Fourth Quarter and Year End 2022 Earnings Conference Call on March 16, 2023
From Panbela Therapeutics, Inc.
Via Globe NewsWire
Panbela Announces First Patient Enrolled in South Korea for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
From Panbela Therapeutics, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
From Panbela Therapeutics, Inc.
Via Globe NewsWire
Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
From Panbela Therapeutics, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Motorsport Games Shares Are Trading Higher By 132%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Dow Surges Over 100 Points; World Acceptance Shares Spike Higher
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
US GDP Rises 2.9% In Q4; Crude Oil Up Over 1%
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Surges 100 Points; Tesla Beats Q4 Views
Via Benzinga
Panbela Announces Pricing of Approximately $15 Million Public Offering
From Panbela Therapeutics, Inc.
Via Globe NewsWire
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.